Cargando…
Therapeutic Effects of an Inhibitor of Thioredoxin Reductase on Liver Fibrosis by Inhibiting the Transforming Growth Factor-β1/Smads Pathway
Liver fibrosis is an important stage in the progression of liver injury into cirrhosis or even liver cancer. Hepatic stellate cells (HSCs) are induced by transforming growth factor-β1 (TGF-β1) to produce α-smooth muscle actin (α-SMA) and collagens in liver fibrosis. Butaselen (BS), which was previou...
Autores principales: | Jiao, Wenxuan, Bai, Man, Yin, Hanwei, Liu, Jiayi, Sun, Jing, Su, Xiaoxia, Zeng, Huihui, Wen, Jinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440796/ https://www.ncbi.nlm.nih.gov/pubmed/34540892 http://dx.doi.org/10.3389/fmolb.2021.690170 |
Ejemplares similares
-
Delivery of the selenoprotein thioredoxin reductase 1 to mammalian cells
por: Wright, David E., et al.
Publicado: (2022) -
Inhibition of Thioredoxin Reductase by Santamarine Conferring Anticancer Effect in HeLa Cells
por: Zhang, Junmin, et al.
Publicado: (2021) -
Thioredoxin Reductase Inhibitors as Potential Antitumors: Mercury Compounds Efficacy in Glioma Cells
por: Pires, Vanessa, et al.
Publicado: (2022) -
Editorial: Small molecule inhibitors targeting mammalian selenoprotein thioredoxin reductases (TXNRDs): Interactions, mechanisms, and applications
por: Xu, Jianqiang, et al.
Publicado: (2023) -
Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer
por: Peng, Wei, et al.
Publicado: (2019)